| | | Single nucleotide variant (missense variant) | Familial type 3 hyperlipoproteinemia +1 more | |
| | | Single nucleotide variant (missense variant) | Lipoprotein glomerulopathy | |
| | | Single nucleotide variant (missense variant) | not provided +7 more | |
| | | Single nucleotide variant (synonymous variant) | Alzheimer disease 2 +7 more | |
| | | Single nucleotide variant (missense variant) | Lipoprotein glomerulopathy | |
| | | Single nucleotide variant (synonymous variant) | Alzheimer disease 3 +8 more | |
| | | Single nucleotide variant (synonymous variant) | Cardiovascular phenotype +8 more | |
| | | | not specified | |
| | | Single nucleotide variant (missense variant) | Alzheimer disease 2 +7 more | |
| | | Single nucleotide variant (missense variant) | Cardiovascular phenotype +8 more | |
| | | Single nucleotide variant (missense variant) | APOE5 VARIANT | |
| | | Single nucleotide variant (missense variant) | Familial hypercholesterolemia +1 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (missense variant) | Familial type 3 hyperlipoproteinemia | |
| | | Single nucleotide variant (missense variant) | Hyperlipoproteinemia due to APOE1 | |
| | | Single nucleotide variant (missense variant) | Familial type 3 hyperlipoproteinemia | |
| | | Single nucleotide variant (missense variant) | Lipoprotein glomerulopathy +6 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (missense variant) | Lipoprotein glomerulopathy | |
| | | Single nucleotide variant (missense variant) | Lipoprotein glomerulopathy | |
| | | Single nucleotide variant (missense variant) | Primary degenerative dementia of the Alzheimer type, presenile onset +4 more | GConflicting classifications of pathogenicity; other; risk factor |